MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202517034912 A) filed by Rinri Therapeutics Limited, Sheffield, U.K., on April 9, for 'laminin cell culture substrate and protocol.'
Inventor(s) include Rivolta Carlos Marcelo Nicolas; and Abbas Leila.
The application for the patent was published on May 2, under issue no. 18/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides an otic neural progenitor (ONP) cell culture substrates comprising a protein matrix composed of laminin (211) laminin (521) and laminin (111) where the amounts of laminin (211) the laminin (521) and the laminin (111) in the otic neural progenitor (ONP) cell culture substrat...